MedTrace Logo

Comparison of 1,550 and 755 Laser in a Split-face Trial

NCT03988049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2021-06-29

Study results available
· View outcomes & findings →

Summary

Clinical Trial comparing the 1,550-nanometer fractionated photothermolysis system laser to the 755 nanometer picosecond laser using a split-face (Right-Left) comparison. Patients will receive laser treatments at week 0, week 4, and week 8. Photographs will be taken prior to laser treatment at each visit, and at the week 24 follow-up visit. Photographs will be reviewed by blinded assessors to rate each side of the face and change from baseline photos.

Conditions

  • Acne Scars - Mixed Atrophic and Hypertrophic

Interventions

DEVICE

1,550 fracionated photothermolysis laser

All subjects will have one side of their face treated with one laser, and the other side with the other laser.

DEVICE

755 picosecond laser

All subjects will have one side of their face treated with one laser, and the other side with the other laser.

Sponsors & Collaborators

  • David Smart

    lead OTHER

Principal Investigators

  • David R Smart, MD · University of Utah

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2019-08-01
Completion
2019-10-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03988049 on ClinicalTrials.gov